Metabolomic analysis of resveratrol-induced effects in the human breast cancer cell lines MCF-7 and MDA-MB-231

OMICS A Journal of Integrative Biology

Volumn 15, Issue 1-2, 2011, Pages 9-14

  Jäger, Walter ^a   Gruber, Alexandra ^b   Giessrigl, Benedikt ^c   Krupitza, Georg ^c   Szekeres, Thomas ^c   Sonntag, Denise ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b BIOCRATES LIFE SCIENCES AG   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; ARACHIDONIC ACID; ICOSANOID; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; RESVERATROL;

AMINO ACID ANALYSIS; ARTICLE; BREAST CANCER; CANCER CELL; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; METABOLOMICS; STILBENES;

VITACEAE;

EID: 79551519567     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2010.0114     Document Type: Article

References (20)

1. Anderson, W.F., Umar, A., and Hawk, E.T. (2003). Cyclooxgenase inhibition in cancer prevention and treatment. Expert Opin Pharmacother 4, 2193-2204.
2. Bove, K., Lincoln, D.W., and Tsan, M.F. (2002). Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem Biophys Res Commun 291, 1001-1005.
3. Deberardinis, R.J., Sayed, N., Ditsworth, D., and Thompson, C.B. (2008). Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18, 54-61.
4. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., and Guittet, O. (1998). Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421, 277-279.
5. Garvin, S., Ollinger, K., and Dabrosin, C. (2006). Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 231, 113-122.
6. Gieger, C., Geistlinger, L., Altmaier, E., Hrabe de Angelis, M., Kronenberg, F., Meitinger, T., et al. (2008). Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 4, e1000282.
7. Horvath, Z., Saiko, P., Madlener, S., Hoechtl, T., Bauer, W., Erker, T., et al. (2005). Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. Exp Hematol 33, 329-335.
8. Lambert, I.H. (2007). Activation and inactivation of the volumesensitive taurine leak pathway in NIH3T3 fibroblasts and Ehrlich Lettre ascites cells. Am J Physiol Cell Physiol 293, 390-400.
9. Milovic, V., Stein, J.E.,Odera, G., Gilani, S., and Murphy, G.M. (2000). Low-dose deoxycholic acid stimulates putresine uptake in colon cancer cells (Caco-2). Cancer Lett 154, 195-200.
10. Miksits, M., Wlcek, K., Svoboda, M., Kunert, O., Haslinger, E., Thalhammer, T., et al. (2010). Antitumor activity of resveratrol and its sulfated metabolites against human breast cacner cells. Planta Medica 75, 1-4.
11. Murias, M., Handler, N., Erker, T., Pleban, K., Ecker, G., Saiko, P., et al. (2004). Resveratrol analogues as selective cyclooxygenase- 2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12, 5571-5578.
12. Murias, M., Miksits, M., Aust, S., Spatzenegger, M., Thalhammer, T., et al. (2008). Metabolism of resveratrol in breast cacner cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 261, 172-182.
13. Nakagawa, H., Kiyozuka, Y., Uemura, Y., Senzaki, H., Shikata, N, Hioki, K., et al. (2001). Resveratrol inhibits human breastcancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J Cancer Res Clin Oncol 127, 258-264.
14. Nazarewicz, R., Zenebe, W.J., Parihar, A., Parihar, M.S., Vaccaro, M., Rink, C., et al. (2007). 12(S)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium. Arch Biochem Biophys 468, 114-120.
15. Pozo-Guisado, E., Alvarez-Barrientos, A., Mulero-Navarro, S., Santiago-Josefat, B., and Fernandez-Salguero, P.M. (2002). The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem Pharmacol 64, 1375-1386.
16. Ragione, F.D., Cucciolla, V., Boriello, A., Pietra, V.D., Racioppi, L., Soldati, G., et al. (1998). Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 250, 53-58.
17. Schneider, Y., Chabert, P., Stutzmann, J., Coelho, D., Fougerousse, A., Gosse, F., et al. (2003). Resveratrol analog (Z)-3,5,40- trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer 107, 189-196.
18. Takao, K., Rickhag, M., Hegardt, C., Oredsson, S., and Persson, L. (2006). Induction of apoptotic cell death by putrescine. Int J Biochem Cell Biol 38, 621-628.
19. Weinberger, K.M., and Graber, A. (2005). Using comprehensive metabolomics to identify novel biomarkers. Screen Trends Drug Discov 6, 42-45.
20. Wolter, F., Turchanova, L., and Stein, J. (2003). Resveratrolinduced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis 24, 469-474.